Search details
1.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36482190
2.
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
Curr Treat Options Oncol
; 22(8): 69, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-34110510
3.
Medical treatment for cholangiocarcinoma.
Liver Int
; 39 Suppl 1: 123-142, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30892822
4.
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy.
Gastric Cancer
; 20(1): 156-163, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-26796888
5.
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma.
Future Oncol
; 11(13): 1905-17, 2015.
Article
in English
| MEDLINE | ID: mdl-26161927
6.
Lgr5 expression, cancer stem cells and pancreatic cancer: results from biological and computational analyses.
Future Oncol
; 11(7): 1037-45, 2015.
Article
in English
| MEDLINE | ID: mdl-25804119
7.
[Treatment of pancreatic cancer. Actuality and perspective]. / Trattamento del carcinoma del pancreas. Attualità e prospettive.
Recenti Prog Med
; 106(5): 208-16, 2015 May.
Article
in Italian
| MEDLINE | ID: mdl-25994537
8.
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer.
J Clin Med
; 13(9)2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38731090
9.
Role of ß4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab.
Future Oncol
; 9(8): 1207-14, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23617461
10.
Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
Cancers (Basel)
; 15(21)2023 Oct 28.
Article
in English
| MEDLINE | ID: mdl-37958363
11.
Impact of Signet-Ring Cell Histology in the Management of Patients with Non-Metastatic Gastric Cancer: Results from a Retrospective Multicenter Analysis Comparing FLOT Perioperative Chemotherapy vs. Surgery Followed by Adjuvant Chemotherapy.
Cancers (Basel)
; 15(13)2023 Jun 25.
Article
in English
| MEDLINE | ID: mdl-37444451
12.
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.
Ther Adv Med Oncol
; 15: 17588359231212184, 2023.
Article
in English
| MEDLINE | ID: mdl-38107830
13.
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
J Transl Med
; 10: 71, 2012 Apr 10.
Article
in English
| MEDLINE | ID: mdl-22490361
14.
Selecting the best treatment for an individual patient.
Recent Results Cancer Res
; 196: 307-18, 2012.
Article
in English
| MEDLINE | ID: mdl-23129382
15.
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab.
Oncologist
; 16(1): 53-60, 2011.
Article
in English
| MEDLINE | ID: mdl-21212430
16.
Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practice.
Tumori
; 97(3): 275-9, 2011.
Article
in English
| MEDLINE | ID: mdl-21789002
17.
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.
Front Oncol
; 11: 736104, 2021.
Article
in English
| MEDLINE | ID: mdl-34660299
18.
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients.
Curr Oncol
; 28(5): 3525-3536, 2021 09 09.
Article
in English
| MEDLINE | ID: mdl-34590611
19.
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer.
Oncol Lett
; 21(4): 267, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33717264
20.
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
Ann Transl Med
; 9(3): 251, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33708878